The Medicine Maker / Issues / 2016 / Articles / May / Biotherapeutic Protein Characterization Challenges: The NIBRT Perspective
Discovery & Development Analytical Science

Biotherapeutic Protein Characterization Challenges: The NIBRT Perspective

05/04/2016 1 min read

Share

NIBRT are collaborating with Thermo Fisher Scientific and making use of the Thermo Scientific Vanquish Flex UHPLC System for the characterization of monoclonal antibodies. Hear Jonathan’s view of where intact antibody analysis and glycan analysis of these novel protein biologics will take us in the future and how he plans to test whether the Vanquish Flex UHPLC system was truly Built for Biopharma. Find out more: www.thermoscientific.com/builtforbiopharma

Please log in or sign up to view video

Recommended

Related Content

Electrifying R&D Acceleration
Small Molecules Analytical Science
Electrifying R&D Acceleration

December 2, 2014

0 min read

Electrochemical reaction cells are finding new applications in the pharma R&D lab that could offer big time and cost savings...

The Lab of the Future: Combining Automation with Digital Tools
Contract Development Services Analytical Science Technology and Equipment Digital Technologies
The Lab of the Future: Combining Automation with Digital Tools

February 25, 2025

6 min read

How do you scale up operations without adding headcount or significantly increasing investment in instrumentation? The answer: automation and workflow scheduling software.

SORS and the Power of Light in Pharma
Ingredients Analytical Science Technology and Equipment
SORS and the Power of Light in Pharma

January 17, 2025

7 min read

Understanding the role of spatially offset Raman spectroscopy in identifying raw materials, counterfeit medicines, and more

Facing Up to the New Nemesis of Pharma: Nitrosamines
Quality & Compliance Small Molecules Process Control Analytical Science Ingredients
Facing Up to the New Nemesis of Pharma: Nitrosamines

September 5, 2024

8 min read

What’s going on with nitrosamines in pharmaceutical products? Naiffer Romero, Principal Scientist at the US Pharmacopeia walks us through frequently asked questions.